ZFIN ID: ZDB-FISH-150901-18050
Fish name: s273tTg
Genotype: s273tTg
Targeting Reagent: none
HUMAN DISEASE MODELED by s273tTg
No data available
GENE EXPRESSION
Gene expression in s273tTg
RNA expression No data available
Protein expression
Antibody Antigen Genes Structure Conditions Figures
Ab1-otof chemical treatment by environment: cisplatin Fig. 1 with imageFig. 2 with imageFig. 3 with image from Sanchez et al., 2018
Ab1-otof control Fig. 1 with imageFig. 3 with image from Sanchez et al., 2018
PHENOTYPE
Phenotype in s273tTg
Phenotype Conditions Figures
neuromast has fewer parts of type neuromast hair cell, abnormal chemical treatment by environment: cisplatin Fig. 1 with imageFig. 2 with image from Sanchez et al., 2018
neuromast has fewer parts of type neuromast hair cell, abnormal chemical treatment by environment: neomycin Fig. 3 with image from Sanchez et al., 2018
neuromast has fewer parts of type neuromast hair cell, abnormal chemical treatment by environment: gentamycin Fig. 3 with image from Sanchez et al., 2018
neuromast has fewer parts of type neuromast hair cell, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast has normal numbers of parts of type neuromast hair cell, ameliorated chemical treatment by environment: cisplatin, chemical treatment by environment: quinoxaline Fig. 1 with imageFig. 2 with image from Sanchez et al., 2018
neuromast has normal numbers of parts of type neuromast hair cell, ameliorated chemical treatment by environment: gentamycin, chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast has normal numbers of parts of type neuromast hair cell, normal chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast has number of neuromast hair cell, ameliorated chemical treatment by environment: gentamycin, chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast has number of neuromast hair cell, ameliorated chemical treatment by environment: cisplatin, chemical treatment by environment: quinoxaline Fig. 1 with imageFig. 2 with image from Sanchez et al., 2018
neuromast malformed, abnormal chemical treatment by environment: gentamycin Fig. 3 with image from Sanchez et al., 2018
neuromast malformed, abnormal chemical treatment by environment: neomycin Fig. 3 with image from Sanchez et al., 2018
neuromast malformed, abnormal chemical treatment by environment: cisplatin Fig. 1 with imageFig. 2 with image from Sanchez et al., 2018
neuromast morphology, ameliorated chemical treatment by environment: gentamycin, chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast morphology, ameliorated chemical treatment by environment: cisplatin, chemical treatment by environment: quinoxaline Fig. 1 with imageFig. 2 with image from Sanchez et al., 2018
neuromast morphology, ameliorated chemical treatment by environment: neomycin, chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast morphology, normal chemical treatment by environment: quinoxaline Fig. 3 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle increased occurrence, abnormal chemical treatment by environment: quinoxaline Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle increased occurrence, abnormal chemical treatment by environment: cisplatin, chemical treatment by environment: quinoxaline Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle increased occurrence, abnormal chemical treatment by environment: gentamycin, chemical treatment by environment: quinoxaline Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle increased occurrence, abnormal chemical treatment by environment: neomycin, chemical treatment by environment: quinoxaline Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle occurrence, normal chemical treatment by environment: cisplatin Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle occurrence, normal chemical treatment by environment: neomycin Fig. 6 with image from Sanchez et al., 2018
neuromast support cell mitotic cell cycle occurrence, normal chemical treatment by environment: gentamycin Fig. 6 with image from Sanchez et al., 2018

CITATIONS  (5)